HAE peer analysis
Haemonetics (HAE) against its competitors: price, today's move, 1-year return and market value side by side.
HAE and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BEAM Beam Therapeutics | $26.12 | -4.08% | 9.75% | $2.81B |
| BHC Bausch Health | $8.14 | -0.67% | 23.22% | $3.07B |
| CON Concentra | $39.94 | -1.09% | 98.90% | – |
| ITGR Integer | $126.67 | 0.06% | 100.05% | $4.30B |
| LMAT LeMaitre Vascular | $80.94 | -5.08% | -8.59% | $1.85B |
| PINC PGIM Securitized Income | $49.27 | 0.01% | – | – |
| QDEL QuidelOrtho | $13.89 | 4.83% | -48.19% | $908.62M |
| WRBY Warby Parker | $24.59 | -0.08% | 27.61% | – |
| XRAY Dentsply Sirona | $9.90 | 3.88% | -21.37% | $1.90B |
| HAE Haemonetics | $121.00 | 1.13% | 142.05% | $5.44B |
- HAE's peers: BEAM (Beam Therapeutics), BHC (Bausch Health), CON (Concentra), ITGR (Integer), LMAT (LeMaitre Vascular), PINC (PGIM Securitized Income), QDEL (QuidelOrtho), WRBY (Warby Parker).
Updated 2026-11-02 17:55 UTC